Das et al. (1973) have shown that higher blood concentrations of sulphapyridine (the presumed active metabolite of sulphasalazine) are attained in 'slow acetylators' and this mirrors previous reports that 'slow acetylators' of hydrallazine and isoniazid have a higher incidence of a positive ANF than 'fast acetylators'. Although we have not determined the acetylator status of our patient, both Griffiths & Kane's and Jaup's patients were 'slow acetylators'.
Casereport
with right median and bilateral lateral popliteal nerve lesions, widespread vasculitic rash, cavitating lung lesions (Figure I), and epistaxes; no nasal granulomata were seen and no histological evidence of vasculitis was obtained on muscle biopsy. There was no history of exposure to drugs or industrial chemicals. Creatinine clearance was 87 ml/min and intravenous pyelogram (lVP) was normal ( Figure 2 ). A diagnosis Figure 2 . Serial pyelograms showing development of hydronephrosis while on prednisolone and return to normal following intensive immunosuppression of polyarteritis nodosa with features of Wegener's granulomatosis was made and prednisolone 60 mg daily was started, with resolution of cutaneous vasculitis. However, further cavitating lung lesions developed, creatinine clearance fell to 54 ml/min and in November 1976 groSS bilateral legoedema developed. A repeat IVP showed bilateral hydronephrosis and hydroureter with blockage at the pelvic brim of the ureters, which were medially deviated; an inferior venocavogram showed obstruction at the same level ( Figure 3 ) but no mass in that region was demonstrated by computerized axial tomography: this radiological combination is indicative of retroperitoneal fibrosis. Chlorambucil 6 mg daily was added and continued for seven months, during which time the lung lesions resolved but leg oedema increased and creatinine clearance fell further. Chlorambucil was discontinued in June 1977 because of thrombocytopenia. By now he was grossly cushingoid, having received prednisolone 60 mg daily for twelve months, relapsing on any reduction, In July 1977he received a course of intensive immunosuppression (Table I) , which was well tolerated and effective in a pilot study of patients with connective tissue diseases (Denman et fl. ,1976) . After intensive immunosuppression fresh lesions of cutaneous vasculitis and lung eSlons did not appear, creatinine clearance gradually rose to 82 mljmin and the IVP returned 
to normal. Leg oedema had completely cleared by January 1978, and the mononeuritis multiplex had improved greatly. He has now returned to full-time work after an absence of tW?,and-a-half years. Reduction of prednisolone has continued and he is now taking 5 mg dally with azathioprine 100 mg daily.
Discussion
the combination of idiopathic retroperitoneal fibrosis and polyarteritis nodosa suggests a cOmmon pathogenesis. There is now considerable evidence, chiefly from pathological studies, that retroperitoneal fibrosis begins as a vasculitis. The fibrosis is distinct pathologically from that secondary to malignancy, irradiation, haemorrhage and infection. Although biopsy of large vessels is not possible and inflammation may have subsided late in the disease, vasculitis of ,the aorta or its branches has been demonstrated at post-mortem (Koep & Zuidema 1977 , Mltchinson 1972 or suggested radiographically (Snow et al. 1977) . Fibrosis is most dense in th~midline, usually at the bifurcation of the aorta, and the ureters may be medially deviated; thiSimplies a process extending from the retroperitoneal vessels (Mitchinson 1970) .Moreover, hen the fibrotic process is unilateral it is maximum over the iliac vessels ofthat side. Fibrous b ssue may encase the ureters, blood vessels, gut and biliary tree but is always limited anteriorly Ythe peritoneum, indicating a process beginning in the retroperitoneal space. It is notable that more distant sites of involvement, the mediastinum and lateral cervical region, are also near large blood vessels.
C.hronic inflammatory tissue is found in retroperitoneal biopsies taken to exclude mahgnancy and is extensively infiltrated by lymphocytes, macrophages, fibroblasts and COllagen. Recent work suggests that fibroblasts may be stimulated to produce collagen by ã~r Ogeni c factor secreted by immunologically activated macrophages (Allison et al, 1976) . thlstochemical staining shows progressive maturation of fibrous tissue from the periphery to e midline (Catino et al. 1967) . The rapid relief of hydronephrosis commonly seen with steroid therapy implies that obstruction is first caused by this inflammatory tissue before COllagen is laid down.
Retroperitoneal fibrosis is found in association with other connective tissue diseases, notably polyarteritis nodosa (Carton &Wong 1969) and also immune complex nephritis (Katz et al. 1977) , as well as fibrosis of the thyroid and orbit; these associations suggest systemic rather than local mechanisms in its pathogenesis. Methysergide, hydrallazine, or related compounds are implicated in more than 10% of cases and the disease may abate on their withdrawal. Chemical and viral agents are known to cause vasculitis and could be responsible in the remaining cases. This evidence allows speculation that retroperitoneal fibrosis is initiated by an external agent stimulating formation or deposition of immune complexes in the walls of large vessels, the site being determined by complex size or local haemodynamic factors. The consequent vasculitis permits exudation of plasma rich in immune complexes which tracks in the retroperitoneal space, exciting a chronic inflammatory reaction. Obstruction of hollow organs by this inflammatory tissue will be reversible by steroids only before collagen has been laid down.
The concept of retroperitoneal fibrosis beginning as a vasculitis has practical as well as theoretical implications; in those cases where steroids fail to reverse obstruction, or where it recurs following surgery, cytotoxic drugs given either singly or in combination may be of benefit. The rationale for combinations of cytotoxic drugs is that their proven benefit in the management of known lymphoproliferative disease, such as the leukaemias or Hodgkin's disease, may also apply to the connective tissue diseases which are putatively immunoproliferative. However the value of intensive immunosuppression is unproven and a controlled trial, which is nearing completion at this centre, is essential. A patient with arachnodactyly is described, who also had neuromyopathic and skeletal abnormalities, presenting a clinical picture which has not hitherto been recorded. The known syndromes associated with arachnodactyly are discussed in relation to the unique features of the present case.
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